Sign in

CIK 0001650664 · Non-accelerated filer<br>Smaller reporting company

Editas Medicine, Inc.

Sign in to watch
Ticker
EDIT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
464097528
Phone
617-401-9000
Business address
11 HURLEY ST., CAMBRIDGE, MA, 02141
  1. SC 13G/A Stake Amended Statement of Ownership
  2. 4 Open-market sale EVP, CHIEF SCIENTIFIC OFFICER sold 5,145 shares at $10.06 ($51,745)
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 8-K Event Shareholder vote results
  11. 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 1,123 shares at $11.54 ($12,956)
  12. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 1,527 shares at $11.54 ($17,617)
  13. 4 Grant or award CEO acquired 86,655 shares (grant or award)
  14. 3 Insider Initial Statement of Ownership
  15. 4 Open-market sale EVP, CHIEF BUSINESS OFFICER sold 297 shares at $13.11 ($3,895)
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. DEFA14A Proxy Proxy Materials
  19. DEF 14A Proxy Proxy Statement
  20. 4 Derivatives Options or other derivatives

Page 14 of 37 · 731 filings